跳至主要内容
临床试验/NCT07638150
NCT07638150尚未招募不适用

PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME): A Pilot, Feasibility Study

H. Lee Moffitt Cancer Center and Research Institute1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2026年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
20
试验地点
1

研究概览

简要总结

This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims include assessing changes in body composition, metabolic biomarkers, inflammation, gut microbiome composition, patient-reported outcomes, and clinician-reported surgical recovery metrics.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Newly diagnosed stage I-III breast cancer.
  • Treatment-naïve; no neoadjuvant therapy planned.
  • Surgery scheduled at Moffitt in 1-2 months.
  • Post-menopausal.
  • BMI 28-35 kg/m².
  • NCI Fruit & Vegetable Screener <5 servings/day.
  • Willing to consume only study-provided meals.

排除标准

  • Stage IV/metastatic disease.
  • Prior cancer.
  • Surgery scheduled sooner than 4-5 weeks.
  • NCI FVS ≥5 servings/day.
  • Celiac disease, severe food allergies, severe renal disease, uncontrolled diabetes, or medically prescribed incompatible diets.

研究组 & 干预措施

Mediterranean Diet

Experimental

Participants receive all meals and snacks for 4 weeks, following a standardized Mediterranean diet meal plan.

干预措施: Mediterranean Diet (Other)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验